|
BLTE Belite Bio Inc 1889109 |
| Income Statement |
|
Net Income
|
2025-12-31
|
$-77,611,000.00 |
| Balance Sheet |
|
Current Assets
|
$494,272,000.00 |
|
Assets
|
$780,556,000.00 |
|
Current Liabilities
|
$9,882,000.00 |
|
Liabilities
|
$10,070,000.00 |
|
Equity
|
$770,486,000.00 |
|
Shares Out
|
39339960.00 |
| Cash Flow Statement |
|
Operating Cash Flow
|
$-36,988,000.00 |
|
Investing Cash Flow
|
$-305,107,000.00 |
| Market Analysis |
Market Cap
|
$6,291,246,403.20 |
|
Price
|
$155.20 |
|
BVPS
|
19.59 |
|
PB
|
8.16 |
|
EPS
|
-2.31 |
|
FCF
|
$-37,059,000.00 |
|
| Dividends |
|
Dividend Data Last Updated
|
2026-08-01 09:31:18 |
|
|
| Earnings |
|
Earnings Last Updated
|
2026-08-03 10:01:12 |
|
| Apr |
May |
Jun |
| 2026-03-02 |
-0.38 |
|
|
2026-05-20 |
-0.34 |
|
| Jul |
Aug |
Sep |
|
|
|
|
2025-08-11 |
-0.50 |
|
| Oct |
Nov |
Dec |
|
|
|
|
2025-11-10 |
-0.65 |
|
|
Find a discrepancy? The most accurate way to find company fundamental data is to view BLTE documents filed with the SEC.
BLTE Filings
Clear
